NM_001077415.3:c.575G>A

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 5P and 1B. PP3_StrongPP5BS1_Supporting

The NM_001077415.3(CRELD1):​c.575G>A​(p.Cys192Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000323 in 1,614,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00034 ( 0 hom. )

Consequence

CRELD1
NM_001077415.3 missense

Scores

12
5
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:3

Conservation

PhyloP100: 9.53

Publications

3 publications found
Variant links:
Genes affected
CRELD1 (HGNC:14630): (cysteine rich with EGF like domains 1) This gene encodes a member of a subfamily of epidermal growth factor-related proteins. The encoded protein is characterized by a cysteine-rich with epidermal growth factor-like domain. This protein may function as a cell adhesion molecule. Mutations in this gene are the cause of atrioventricular septal defect. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
PRRT3 (HGNC:26591): (proline rich transmembrane protein 3) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.948
PP5
Variant 3-9940964-G-A is Pathogenic according to our data. Variant chr3-9940964-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 238218.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000125 (19/152178) while in subpopulation NFE AF = 0.000235 (16/68028). AF 95% confidence interval is 0.000147. There are 0 homozygotes in GnomAd4. There are 12 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001077415.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CRELD1
NM_001077415.3
MANE Select
c.575G>Ap.Cys192Tyr
missense
Exon 6 of 11NP_001070883.2Q96HD1-1
CRELD1
NM_001374317.1
c.575G>Ap.Cys192Tyr
missense
Exon 6 of 12NP_001361246.1A0A804HJJ0
CRELD1
NM_001374318.1
c.575G>Ap.Cys192Tyr
missense
Exon 5 of 11NP_001361247.1A0A804HJJ0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CRELD1
ENST00000452070.6
TSL:2 MANE Select
c.575G>Ap.Cys192Tyr
missense
Exon 6 of 11ENSP00000393643.2Q96HD1-1
CRELD1
ENST00000326434.9
TSL:1
c.575G>Ap.Cys192Tyr
missense
Exon 6 of 12ENSP00000321856.5Q96HD1-2
CRELD1
ENST00000383811.8
TSL:1
c.575G>Ap.Cys192Tyr
missense
Exon 5 of 10ENSP00000373322.3Q96HD1-1

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
19
AN:
152178
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000195
AC:
49
AN:
251352
AF XY:
0.000199
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000396
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000344
AC:
503
AN:
1461880
Hom.:
0
Cov.:
33
AF XY:
0.000341
AC XY:
248
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.000134
AC:
6
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000434
AC:
483
AN:
1112012
Other (OTH)
AF:
0.000199
AC:
12
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
32
64
97
129
161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
152178
Hom.:
0
Cov.:
31
AF XY:
0.000161
AC XY:
12
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41446
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000355
Hom.:
0
Bravo
AF:
0.000110
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000181
AC:
22
EpiCase
AF:
0.000382
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Jeffries-Lakhani neurodevelopmental syndrome (2)
1
1
-
not provided (2)
-
1
-
Atrioventricular septal defect, susceptibility to, 2 (1)
-
1
-
CRELD1-related disorder (1)
1
-
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Pathogenic
0.33
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.44
T
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.83
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.80
T
M_CAP
Uncertain
0.12
D
MetaRNN
Pathogenic
0.95
D
MetaSVM
Uncertain
0.061
D
MutationAssessor
Pathogenic
3.4
M
PhyloP100
9.5
PrimateAI
Uncertain
0.79
T
PROVEAN
Pathogenic
-11
D
REVEL
Pathogenic
0.69
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.96
MVP
0.95
MPC
0.89
ClinPred
0.99
D
GERP RS
5.3
PromoterAI
0.025
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.96
gMVP
0.98
Mutation Taster
=24/76
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201866563; hg19: chr3-9982648; API